Enjoy complimentary customisation on priority with our Enterprise License!
The global cancer registry software market size is estimated to grow by USD 97.1 million, at a CAGR of 12.75% between 2023 and 2028. Cancer registries help to maintain and improve patient care and focus on clinical research.
Our cancer registry software market analysis report examines historical data from 2018-2022, besides analyzing the current market scenario. It also includes an in-depth analysis of drivers, trends, and challenges. Registries for cancer are hospital-based and population-based cancer registries that are used in most countries across the globe. To reach goals such as early detection, strengthening of cancer diagnostics, understanding trends, prevention of cancer, understanding the patterns of treatment and outcome, and efforts to control cancer population-based registries are developed by government bodies.
To learn more about this cancer registry software market forecast report, Download Report Sample
The market is experiencing significant growth due to the increasing prevalence of Cancer worldwide. This software plays a crucial role in the collection, management, and analysis of patient data related to Cancer incidence, diagnostics, treatment, and outcomes. The adoption of Electronic Health Records (EHR) and the push towards evidence-based medicine have driven the demand for Cancer Registry Software. Medical professionals, including doctors and nurses, rely on this software to manage patient care and track Cancer-specific outcomes. The software solutions facilitate the recording of data on various therapeutic interventions, such as Surgery, Chemotherapy, and Supportive treatments.
The market share growth by the government and third-party segment will be significant during the forecast period. Cancer Registry Software plays a pivotal role in the healthcare industry, particularly in managing and analyzing data related to cancer cases. This software is essential for governments and third-party agencies to monitor cancer prevalence, identify trends, and evaluate the effectiveness of cancer treatments. The adoption of Electronic Health Records (EHR) and the shift towards evidence-based medicine have increased the demand for cancer registry software. Medical professionals and patients benefit from this software as it facilitates seamless data integration, interoperability, and cancer reporting. Cancer registry software enables the tracking of cancer cases, from diagnosis to treatment and cancer supportive care, including cancer staging, chemo, surgery, and supportive therapies. It provides crucial information for healthcare systems to improve patient care management, medical research, and clinical studies.
Get a glance at the market contribution of various segments Download PDF Sample
The government and third party segment was valued at USD 22.30 million in 2018. Cancer registries store data securely with stringent security protocols, ensuring data privacy and confidentiality. The software allows for cancer screening data to be analyzed, enabling early detection and intervention. By benchmarking outcomes against national or international standards, cancer registry software helps improve the course of cancer treatment and patient care. Integrated software solutions offer additional features, such as cancer diagnostics, disease management, and treatment planning. Pharmaceutical, biotech, and medical device companies also utilize cancer registry software for research and development purposes. The changing landscape of healthcare and the increasing focus on personalized medicine and precision therapies further emphasize the importance of cancer registry software in the healthcare industry.
In the realm of oncology departments and clinics, Cancer registry software solutions play a pivotal role in managing and analyzing data related to Cancer incidence and deaths. These software systems facilitate population health management by enabling the efficient capture, storage, and processing of critical health information data. The use of stand-alone Cancer registry software is particularly beneficial due to its interoperability and ease of use, even in the absence of a connection to other systems. The global market for Cancer registry software is experiencing significant growth, driven by factors such as the need for coordinated care, chronic disease management, and healthcare quality goals. The software solutions contribute to improved healthcare costs by streamlining hospital workflows and enhancing disease registries.
Moreover, they offer features like automatic upgrades, high flexibility, and options for multiple usage systems, making them an essential tool for organizations focused on cancer-specific outcomes. The software vendors catering to this market provide solutions that support health information exchange and disease registries for various types of cancers, including lung cancer and those related to developmental disabilities. The adoption of these software systems is crucial for maintaining cognitive capacities and preventing medical identity theft. By facilitating observational studies and data capture systems, Cancer registry software solutions contribute to the advancement of research and the overall improvement of healthcare services.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 50% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The market plays a crucial role in oncology departments and clinics by facilitating the collection, management, and analysis of Healthcare data related to Cancer. This data is essential for tracking the incidence of cancer, Cancer deaths, and population health management. Software solutions enable healthcare providers to record cancer-specific outcomes, coordinate care, and manage chronic diseases, contributing significantly to healthcare quality goals. Health information exchange and disease registries are integral components of cancer registry software. They allow for the secure sharing of health information data between healthcare providers, ensuring accurate and timely diagnosis and treatment.
Further, the software also caters to specialized areas such as lung cancer and developmental disabilities, addressing the unique needs of these patient populations. Cancer registry software is essential in the fight against Medical identity theft, ensuring the protection of patients' cognitive capacities and maintaining the integrity of hospital workflows. Software vendors provide observational studies and data capture systems, enabling researchers to analyze trends and patterns in cancer data, ultimately leading to advancements in cancer research and treatment. The software solutions also support coordinated care and chronic disease management, enabling healthcare providers to deliver personalized care plans to patients. By focusing on disease-specific outcomes and healthcare quality goals, cancer registry software plays a vital role in reducing healthcare costs and improving overall patient care.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The cancer registry software market analysis report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Conduent Inc., Elekta AB, ERS Inc., Inspirata Inc., International Association of Cancer Registries, International Business Machines Corp., McKesson Corp., NeuralFrame Inc., OMH HealthEdge Holdings LLC, Onco Inc., Ordinal Data Inc., Redsson Ltd., Siemens AG, and University of Utah Health
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Further, cancer Registry Software is essential for the development of Guidance documents and the improvement of Cancer treatment protocols. The software also aids in the monitoring of healthcare costs and the management of Cancer registries. In the specific area of diagnostics, Cancer Registry Software can help in the analysis of post-endoscopic resection data, leading to more accurate and timely diagnoses. In conclusion, the market is a vital component of the Healthcare industry, providing essential tools for managing Cancer patient care and advancing Cancer research and treatment. Our researchers analyzed the market research and growth data with 2023 as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage.
The growing prevalence of cancer cases is the key factor driving the market. Cancer prevalence continues to be a significant concern in healthcare systems worldwide, with the disease being the second leading cause of death globally. According to the World Health Organization, there were approximately 19.3 million new cancer cases and 10 million cancer-related deaths in 2020. In the US and European countries, breast, cervical, and prostate cancers are among the most common types. To effectively manage and treat cancer, medical professionals require access to accurate and timely patient data. Cancer registry software plays a crucial role in this regard, facilitating seamless data integration and interoperability between healthcare systems. This data is essential for cancer staging, treatment planning, and disease management. The adoption of electronic health records (EHR) and evidence-based medicine has led to an increased demand for cancer registry software.
Additionally, cancer reporting and patient care management features can help healthcare providers deliver personalized and effective cancer care to their patients. In conclusion, cancer registry software is an essential tool for managing and treating cancer, enabling medical professionals to access accurate and timely patient data for cancer staging, treatment planning, and disease management. It supports cancer reporting, patient care management, medical research, and clinical studies, making it an indispensable component of modern healthcare systems.
Increasing clinical research for oncology is the primary trend shaping the market. Cancer registries play a crucial role in the advancement of cancer treatment and diagnostics by providing access to comprehensive data on cancer prevalence and patient outcomes. Medical professionals and researchers utilize this information to make evidence-based decisions regarding therapeutics, cancer staging, and treatment modalities, including chemo, surgery, and supportive therapies. The adoption of electronic health records (EHR) has facilitated the seamless integration of cancer registry data into healthcare systems, enabling interoperability and improved patient care management. Cancer registries store data on cancer cases, screenings, and disease progression, which is essential for cancer reporting and research purposes.
Further, pharmaceutical, biotech, and medical device companies, as well as research institutes and hospitals, rely on these registries to gain insights into the changing landscape of cancer treatment and patient care. Integrated software solutions offer enhanced security protocols and data security features, ensuring the confidentiality and accuracy of sensitive patient information. The use of cancer registry software supports medical practices and healthcare systems in providing optimal care to cancer patients throughout the course of their disease. By facilitating the collection, analysis, and reporting of data on cancer cases, cancer registries contribute to the development of new cancer treatments, improved patient outcomes, and overall advancements in cancer care.
Data privacy and security concerns| is the major challenge that affects the market growth. Cancer registries play a crucial role in collecting and maintaining data on cancer prevalence, tumor characteristics, and treatment outcomes for cancer patients. This information is sourced from various healthcare facilities, including hospitals, outpatient clinics, radiology departments, physician offices, laboratories, and surgical centers. The data collected is highly confidential and must be safeguarded to protect the privacy and confidentiality of cancer patients and their families. The adoption of electronic health records (EHR) and evidence-based medicine has led to an increased demand for cancer registry software. This software facilitates seamless data integration and interoperability between healthcare systems, enabling medical professionals to access accurate and up-to-date patient information for cancer diagnostics, staging, treatment planning, and disease management.
Furthermore, cancer registry software supports the recording of cancer cases, cancer screenings, and various cancer treatments, including chemotherapy, surgery, and supportive therapies. It also enables cancer reporting, patient care management, and medical research, facilitating improved cancer care and clinical studies in research institutes, hospitals, medical practices, pharmaceutical, biotech, and medical device companies. The changing landscape of healthcare and the growing importance of data security have made it essential for cancer registry software to incorporate stringent security protocols to protect sensitive patient data. The software must store data securely and provide access only to authorized medical professionals, ensuring the confidentiality and integrity of cancer patient information.
The cancer registry software market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the cancer registry software market growth and trends report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
The market forecasting report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The market is a significant sector in the healthcare industry, catering to the essential requirement of maintaining and analyzing cancer data. This software plays a crucial role in tracking, managing, and reporting cancer incidences and survivorship data. The market is driven by various factors, including the increasing prevalence of cancer, growing awareness about early detection, and the need for efficient data management. Cancer Registry Software enables healthcare providers to store, manage, and retrieve patient data, including demographic information, diagnosis, treatment, and follow-up data. It also facilitates data analysis, enabling researchers and healthcare professionals to identify trends, patterns, and outcomes in cancer care and accordingly prioritize activities related to cancer biologics. The market is expected to grow substantially due to the rising incidence of cancer worldwide.
The software's ability to improve patient care, enhance research capabilities, and streamline administrative processes further boosts its adoption. Additionally, governments and regulatory bodies' increasing focus on cancer data collection and reporting adds to the market's growth potential. In conclusion, Cancer Registry Software is a vital tool in the healthcare industry, offering numerous benefits to healthcare providers, researchers, and patients. Its growing importance is reflected in the market's significant growth potential. Electronic Health Records (EHRs) and the adoption of EHR revolutionize healthcare, aiding in tracking diseases worldwide. Cancer patient registry data integrated with EHRs (Electronic Health Records) informs treatment strategies. Understanding drug/medical device exposure is critical. Tools like cancer patient registry software, endorsed by the European Society of Gastrointestinal Endoscopy, enhance data management, fostering collaboration for better patient outcomes."
Market Scope |
|
Report Coverage |
Details |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 12.75% |
Market growth 2024-2028 |
USD 97.1 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
11.43 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 50% |
Key countries |
US, Germany, Italy, China, and Canada |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
CDC, Conduent Inc., Elekta AB, ERS Inc., Inspirata Inc., International Association of Cancer Registries, International Business Machines Corp., McKesson Corp., NeuralFrame Inc., OMH HealthEdge Holdings LLC, Onco Inc., Ordinal Data Inc., Redsson Ltd., Siemens AG, and University of Utah Health |
Market dynamics |
Parent market analysis, Cancer registry software market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Cancer registry software market worth and condition analysis for forecast period. |
Customization purview |
If our cancer registry software market forecast report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this cancer registry software market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.